Mammography screening;Mammographiescreening

Radiologe

Volumn 47, Issue 4, 2007, Pages 359-370

  Schulz Wendtland, R ^a   Becker, N ^b   Bock, K ^c   Anders, K ^a   Bautz, W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Breast cancer; Guidelines; Mammography screening; Mortality; Quality assurance

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; COMPUTER ASSISTED RADIOGRAPHY; COST BENEFIT ANALYSIS; ECHOMAMMOGRAPHY; HISTOLOGY; HUMAN; MAMMOGRAPHY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; QUALITY CONTROL; RADIODIAGNOSIS; REVIEW; SCREENING; TUMOR VOLUME;

BREAST NEOPLASMS; EUROPE; FEMALE; GERMANY; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 34247347345     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-007-1490-z     Document Type: Review

References (27)

1. Becker N (2002) Screening aus epidemiologischer Sicht. Radiologe 42: 592-600
2. Becker N (2006) Die Rolle der epidemiologischen Qualitätsparameter im Mammographie-Screening-Programm. Radiologe 46: 984-992
3. Becker N, Hakama M, Nyström L (2007) Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options. Eur J Cancer Prev in press
4. Beckmann MW, Fasching PA, Aichinger U et al. (Hrsg) (2001) Diagnostik und Abklärung von Mammaveränderungen im Rahmen der gesetzlichen Krebsfrüherkennung. Teil I: Inzidenz, Risikofaktoren, Risikobeurteilung, Grundlage des Krebsfrüherkennungsprogrammes. Geburtshilfe und Frauenheilkunde. Thieme, Stuttgart New York
5. Bick U (2006) Mammographie-Screening in Deutschland: wie, wann und warum? Fortschr Röntgenstr 178: 957-969
6. Erbas B, Provenzano E, Armes J et al. (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97: 135-144
7. Gøtzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355: 129-134; 747-752
8. Hakama M, Pukkala E, Heikkilä M et al. (1997) Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 314: 864-872
9. IARC (ed) (2002) Breast cancer screening. IARC handbooks of cancer prevention, volume 7. International Agency for Research on Cancer. World Health Organization. IARC Press, Lyon
10. Jonsson H, Nyström L, Törnberg S et al. (2001) Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8: 152-160
11. Junkermann H, Becker N, Peitgen HO (2001) Konzept und Durchführung der Modellprojekte für Mammographiescreening in Deutschland. Radiologe 41: 328-336
12. Junkermann H, Reichel M, Hecht G et al. (2005) Ist eine deutliche Senkung der Brustkrebssterblichkeit durch Mammographie-Screening in Deutschland erreichbar? Senologie 2: 172
13. Kääb V, Wulf T, Becker N et al. (2006) Mammographie-Screening in Deutschland - Abschlussbericht der Modellprojekte. Kooperationsgemeinschaft Mammographie, Köln
14. NN (2004) Einführung eines bundesweiten Mammographie-Screening- Programms (BMV-Ä/EKV). Dtsch Arztebl 4: 1-44
15. Nyström L, Andersson I, Bjurstam N et al. (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359: 909-919
16. Otten JD, Karssemeijer N, Hendriks JH et al. (2005) Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 97: 748-754
17. Otto SJ, Fracheboud J, Looman CWN et al. (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361: 1411-1417
18. Perry N, Broeders M, Wolf C de et al. (eds) (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg
19. Säbel M, Aichinger U, Schulz-Wendtland R (2001) Die Strahlenexposition bei der Röntgen-Mammographie. Fortschr Röntgenstr 173: 79-91
20. Schulz-Wendtland R, Aichinger U, Brumm C et al. (Hrsg) (2001) Diagnostik und Abklärung von Mammaveränderungen im Rahmen der gesetzlichen Krebsfrüherkennung. Teil II: Wertigkeit und Technik. Geburtshilfe und Frauenheilkunde. Thieme, Stuttgart New York
21. Schulz-Wendtland R, Hermann KP, Bautz W (2005) Clinical results of digital mammography. Radiologe 45: 255-263
22. Sittek H, De Waal JC, Eiermann W et al. (2003) Screening und Diagnostik. In: Tumorzentrum München (Hrsg) Manual Mammakarzinome. Zuckschwerdt, München
23. Tabár L, Chen H-H, Duffy SW et al. (2000) A novel method for prediction of long-term outcome of women with T1a, T1b and 10-14 mm invasive breast cancers: a prospective study. Lancet 355: 429-433
24. Tabár L, Vitak B, Chen H-H et al. (2000) The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 38: 625-651
25. Tabar L, Yen M-F, Vitak B et al. (2003) Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361: 1405-1410
26. Wald NJ, Murphy P, Major P et al. (1995) UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 311: 1189-1193
27. Wilson JMG, Jungner G (1968) Principles and practice of screening for disease. World Health Organisation, WHO Public Health, Paper 34